Travoprost is widely employed as a medicine to lower elevated Intraocular pressure levels. This medication comes in the form of eye drops and may be acquired from a leading pharmacy, chemist store, or any online pharmacy.
Travoprost treats various eye conditions, including Glaucoma and Ocular Hypertension.
Additionally, it is used in beauty businesses for cosmetic purposes, such as lengthening eyelashes and other applications.
Let’s look at the ways in which Bimatoprost and Travoprost solutions work to create their effects, as well as the parallels and divergences between the two.
For Treating Hypotrichosis
Hypotrichosis is an inherited condition that can lead to a pattern of hair loss in particular areas of the body. It is present in a person from the time they are born and affects their scalp. When this problem lasts for a long time, the hair will usually become rough, fragile, and frizzy over time.
Hypotrichosis shows itself in many ways, one of which is that the eyelashes are too thin and fall out more often than usual.
Many people now regularly use medicated eye drops to keep their symptoms under control. Also, it helps to make their eyelashes grow faster.
As the findings of various studies have shown, Bimatoprost is superior to other treatments. It encourages the growth of eyelashes in patients diagnosed with Hypotrichosis.
Hypotrichosis is a genetic illness that can cause a pattern of hair loss localized to specific body parts. It is one of the symptoms of the condition. It is present in the individual from birth onwards and affects the scalp of the person. When exposed to this condition for an extended period, the hair will, in most cases, become harsh, brittle, and spiraled over time.
Hypotrichosis manifests in some ways, one of which is that the eyelashes are abnormally thin and shed more often than usual.
As a result, a remarkable number of individuals start using eye drops to control their condition and stimulate the growth of their eyelashes.
Different studies have shown that Bimatoprost is better than other ways to help people with Hypotrichosis grow eyelashes than other treatments.
Bimatoprost Ophthalmic solutions are twice more effective as Travoprost in the treatment of Hypotrichosis.
It means that if you wish to get fuller and more beautiful eyelashes, Bimatoprost will do it seemingly.
Travoprost eye drops, on the other hand, are comparatively less effective.
Glaucoma & Ocular Hypertension Treatment
Most of the time, Ocular Hypertension is the cause of high eye pressure.
However, it excludes any optic nerve injury or instances of visual loss.
In contrast, Glaucoma is a cumulative disease of the eyes that worsens with time.
It depicts the degeneration of the physical state of the optic nerve and, in certain circumstances, eyesight changes.
However, Ocular Hypertension is not necessarily the direct cause of Glaucoma.
It could still exist under normal circumstances, though the likelihood of this happening is relatively small.
Bimatoprost was more effective than Travoprost at lowering Intra Ocular Pressure (IOP) from baseline on average and helping patients reach and sustain their low target pressures.
As per studies, the weighted mean IOP reduction of Travoprost eye drops was 28.7%, whereas Bimatoprost succeeded with a value of 30.3%.
Based on these results, it appears that Bimatoprost is a better treatment option for reducing IOP than Travoprost eye drops.
Travoprost eye drops are associated with several unwanted side effects in people with Glaucoma.
A few patients accounted for cases of visual impairment or blurring.
A few patients experienced side effects, most notably eye pain and puffiness.
Some individuals also showed signs of a change in eye color after using Travoprost eye drops.
Why Should You Buy Bimatoprost?
In comparison to Travoprost, doctors recommend Bimatoprost due to its superior efficacy.
It works significantly better than Travoprost for treating and preventing Hypotrichosis and developing eyelashes.
Bimatoprost helped lower Ocular Hypertension to a more significant extent and helped relieve patients with Glaucoma.
Additionally, Bimatoprost’s possible adverse effects were limited when weighed against the advantages.